News

The Dose Podcast - Episode 2 "Translating the UNHLM Commitments into Action"


19 Dec 2018
by Working Group

Episode 2: "Translating the UNHLM Commitments into Action: Ensuring Investment in TB R&D to eliminate TB" 

The second episode of The Dose Podcast will focus on the first ever High-Level Meeting on Tuberculosis held by the United Nations General Assembly and the commitments made there to fight TB. The High-Level Meeting is only the fifth time that the UN in its history has called for a high-level meeting devoted to a health issue.  This podcast will highlight the outcomes resulting from the UNHLM, consider how we can hold countries accountable to their commitments, as well as drive the momentum in development of new TB therapies, vaccines and diagnostics.

Moderator: Bobby Ramakant, Citizen News Service

Speaker: Honorable Nick Herbert, Member of Parliament for Arundel and South Downs in the UK.

Speaker: Blessi Kumar, CEO of the Global Coalition of TB Activists

Listen on Soundcloud: https://soundcloud.com/user-87209407/the-does-podcast-episode-2-translating-the-unhlm-commitments-into-action

More News
29 Jul 2020
The WGND is announcing a call for applications to become a part of the WGND Core Group (CG). The CG provides leadership and sets the strategic direction for the work of the WGND. Addmitted applicants will begin their term in September 2020. Current CG membership information is available on the WGND...
9 Jul 2020
Earlier this week, Johnson & Johnson announced a reduction in the price for bedaquiline in low- and middle-income countries, as part of a collaboration with the Stop TB Partnership's Global Drug Facility (GDF). The immediate change in price will make bedaquiline available through the GDF at the...
18 Jun 2020
On May 21st, Antimicrbial Agents and Chemotherapy published an article on Otsuka's novel anti-tuberculosis compound, OPC-167832. This molecule, a DprE1 inhibitor, demonstrated potent bactericidal activity and exhibited significant combination effects in 2-drug combinations with delamanid,...